EMCURE
Active threads
Emcure Pharma gets USFDA approval
2 Min Read Emcure Pharma has received a United States Food and Drug Administration EIR for the Sanand formulations facility in Gujarat. In an exchange filing issued on August 8, the Pune-based drug maker said that its recieved the Establishment Inspection Report (EIR) after the USFDA inspected the company’s formulations facility located at Sanand, Ahmedabad. The US drug regulator conducted this inspection from May 06, 2026 to May 15, 2026.
Emcure gets India approval for MASH treatment
3 Min Read Pharmaceutical company Emcure Pharmaceuticals Ltd on Monday (July 20) announced that its co-marketed brand Poviztra can now be used for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (F2-F3), following approval from the Central Drugs Standard Control Organisation (CDSCO).
Intelligence feed
No articles in the last 24 hours.